Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-blind, Randomized, Investigator-initiated Trial to Evaluate the Degree of Symptom Relief of Zastaprazan and Esomeprazole in Patients With Erosive Reflux Disease With Night-time Heartburn Symptoms

NCT07268820 is registered in ClinicalTrials.gov with Incheon St.Mary's Hospital as lead sponsor.

NCT NCT07268820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07268820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-blind, Randomized, Investigator-initiated Trial to Evaluate the Degree of Symptom Relief of Zastaprazan and Esomeprazole in Patients With Erosive Reflux Disease With Night-time Heartburn Symptoms
Lead sponsor
Incheon St.Mary's Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
July 7, 2025
Completion date
September 30, 2026
Enrollment
160 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

gerd